Ovarian Cancer Life Expectancy and Avastin
Links shared publicly online about this topic
Roche's Pricy Avastin May Slow Ovarian Cancer Progression
medicalnewstoday.com — “Roche's blockbuster cancer drug Avastin has now additionally been shown to slow the progression of ovarian cancer but does not extend life necessarily according to information presented at this we” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 7:05 pm By:
MNT Ovarian Cancer Health News
Roche's Pricy Avastin May Slow Ovarian Cancer Progression http://mnt.to/3WPr #ovariancancer
Roche's Avastin: Four More Months Of Life Worth The Cost?
medicalnewstoday.com — “Many prescription medications issued to treat potentially fatal ovarian cancer in women are quite expensive. Now in a recent study, Roche's Avastin (bevacizumab) is being called into question and” View full resource at medicalnewstoday.com
Most Recently Shared on March 9, 2011 at 9:05 am By:
Roche's Avastin: Four More Months Of Life Worth The Cost? http://mnt.to/3S3D #healthnews
Roche's Avastin: Four More Months Of Life Worth The Cost?
medicalnewstoday.com — “Many prescription medications issued to treat potentially fatal ovarian cancer in women are quite expensive. Now in a recent study, Roche's Avastin (bevacizumab) is being called into question and” View full resource at medicalnewstoday.com
Most Recently Shared on March 10, 2011 at 6:56 am By:
Roche's Avastin: Four More Months Of Life Worth The Cost?: Many prescription medications issued to treat potent... http://bit.ly/f6R043
Ovarian cancer research (ASCO 2010) Video
vodpod.com — “Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is research targeting the VEGF protein. A key presentation at ASCO 2010 has shown that a maintenance treatment of avastin, a targeted therapy that blocks VEGF, increases overall survival in ovarian cancer patients. The second area discussed is research into PARP inhibitors. After some spectacular initial results in women with BRCA mutations, a trial presented at ASCO 2010 has shown that ol” View full resource at vodpod.com
Most Recently Shared on July 21, 2010 at 5:00 am By:
Paul Cacciatore Patient Advocate
Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is researc… http://bit.ly/bROVq0
NHS Evidence - Gastroenterology and liver diseases - Palliative surgery versus medical management for bowel obstruction in ovarian cancer
library.nhs.uk — “Background Ovarian cancer is the sixth most common cancer among women and is usually diagnosed at an advanced stage. Bowel obstruction is a common feature of advanced or recurrent ovarian cancer. Patients with bowel obstruction are generally in poor physical condition with a limited life expectancy. Therefore, maintaining their QoL with effective symptom control is the main purpose of the management of bowel obstruction. Objectives To compare the effectiveness and safety of palliative surgery (s” View full resource at library.nhs.uk
Most Recently Shared on July 13, 2010 at 11:53 am By:
Palliative surgery versus medical management for bowel obstruction in ovarian cancer: Background Ovarian cancer is... http://bit.ly/cTpcq3
USA Today Publishes Opposing Opinions On Avastin For Breast Cancer Treatment
medicalnewstoday.com — “USA Today recently published an editorial and an opinion piece regarding the recent controversy surrounding the cancer drug Avastin. An FDA advisory panel in July voted 12-1 to recomm” View full resource at medicalnewstoday.com
Most Recently Shared on August 26, 2010 at 5:00 pm By:
USA Today Publishes Opposing Opinions On Avastin For Breast Cancer Treatment http://mnt.to/3HTv #breastcancer
Medical News: ASCO: Avastin Boosts Survival in High-Risk Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Adding an anti-angiogenic agent to chemotherapy appears to prolong life in women with high-risk ovarian cancer, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on June 6, 2011 at 1:19 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday ASCO: Avastin Boosts Survival in High-Risk Ovarian Ca (with video) http://bit.ly/j0YUkm #medical #Health
Medical News: ASCO: Avastin Boosts Survival in High-Risk Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Adding an anti-angiogenic agent to chemotherapy appears to prolong life in women with high-risk ovarian cancer, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:25 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: ASCO: Avastin Boosts Survival in High-Risk Ovarian Ca - http://t.co/x2BJ6h8 from @medpagetoday #health #medicine
USA Today Publishes Opposing Opinions On Avastin For Breast Cancer Treatment - QualityPoint Technologies
qualitypointtech.net — “USA Today recently published an editorial and an opinion piece regarding the recent controversy surrounding the cancer drug Avastin. An FDA advisory panel in July voted 12-1 to recommend that the agency revoke Avastin's approval to treat advanced breast cancer after two clinical trials showed it did not prolong life. FDA is expected to make its final decision by Sept. 17, USA Today reports. ~ USA Today: The debate over Avastin” View full resource at qualitypointtech.net
Most Recently Shared on August 26, 2010 at 3:12 pm By:
USA Today Publishes Opposing Opinions On Avastin For Breast Cancer Treatment: USA Today recently published an edit... http://bit.ly/bFrji7
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
-
Ovarian Cancer OW
Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
